| Patient | Paul Robeson |
|---|---|
| Date of birth | 1967-04-09 |
| Identifiers | MRN HR-ML048-SYN; SSN (made up) 000-48-2647 |
| Document date | 2026-07-27 |
| Author | Theodore Bankole-Ashworth, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Cough for five days after a cold. [S]
Mr. Robeson called this morning and was seen the same day. A week ago he had a sore throat and a runny nose, and for five days he has had a cough, worse at night, with a little clear sputum. He has had no fever, breathlessness, chest pain or blood in the sputum. The cough is keeping him awake and he wants to protect his voice. He bought a nighttime cold medicine but did not take it after reading that it contained dextromethorphan and remembering the warning about venlafaxine. He takes venlafaxine 225 mg each morning, three weeks at the full dose, with mild sweating and no other side effects. His mood is a little better than in the spring; he goes to his therapy sessions each week and walks most mornings. He has had no thoughts of suicide or of being better off dead. [S]
| Element | Detail |
|---|---|
| Onset | Cough for five days after a cold a week ago |
| Character | Cough with a little clear sputum, worse at night |
| Severity | Disturbing his sleep; no breathlessness |
| Context | Venlafaxine 225 mg daily; has avoided a dextromethorphan cold remedy |
| Associated signs and symptoms | No fever, chest pain or blood in the sputum |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or chills; tired from broken sleep |
| Ears, nose, mouth, and throat | Positive | Sore throat and runny nose last week, now settling; voice a little hoarse |
| Respiratory | Positive | Cough with clear sputum; no wheeze, breathlessness or hemoptysis |
| Cardiovascular | Negative | No chest pain or palpitations |
| Psychiatric | Positive | Mood low but improving; no thoughts of suicide |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg tablet, one tablet each morning | 50 mg each morning for two weeks | Oral route | 2026-03-12 to 2026-03-25 | completed | S |
| Sertraline 100 mg tablet, one tablet each morning | 100 mg each morning | Oral route | 2026-03-26 to 2026-04-19 | completed | S |
| Sertraline 50 mg tablets, three tablets (150 mg) each morning | 150 mg each morning for two weeks | Oral route | 2026-04-20 to 2026-05-03 | completed | S |
| Sertraline 100 mg tablets, two tablets (200 mg) each morning | 200 mg each morning | Oral route | 2026-05-04 to 2026-06-07 | completed | S |
| Sertraline 100 mg tablet, one tablet each morning for one week, then stop | 100 mg each morning for one week during the switch | Oral route | 2026-06-08 to 2026-06-14 | completed | S |
| Venlafaxine extended-release 75 mg capsule, one capsule each morning with food | 75 mg each morning for one week | Oral route | 2026-06-08 to 2026-06-14 | completed | S |
| Venlafaxine extended-release 150 mg capsule, one capsule each morning with food | 150 mg each morning for three weeks | Oral route | 2026-06-15 to 2026-07-05 | completed | S |
| Venlafaxine extended-release 75 mg capsules, three capsules (225 mg) each morning with food | 225 mg each morning; 30-day supply at a time | Oral route | 2026-07-06 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-27 | Body height | 190 | cm | S |
| 2026-07-27 | Body weight | 100.6 | kg | S |
| 2026-07-27 | Body mass index (BMI) [Ratio] | 27.9 | kg/m2 | S |
| 2026-07-27 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-07-27 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-07-27 | Heart rate | 84 | /min | S |
| 2026-07-27 | Respiratory rate | 16 | /min | S |
| 2026-07-27 | Body temperature | 37.4 | Cel | S |
| 2026-07-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
Vital signs recorded on 2026-07-27; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Comfortable; temperature 37.4 °C, pulse 84, respiratory rate 16, oxygen saturation 97 percent, blood pressure 132/82 |
| Ears, nose, mouth, and throat | Mild pharyngeal redness; no exudate; ears normal |
| Respiratory | Scattered rhonchi that clear with coughing; no crackles, wheeze or bronchial breathing |
| Cardiovascular | Regular rhythm |
| Psychiatric | Calm, brighter than in the spring; no thoughts of suicide |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| About three months of low mood, exhaustion, poor sleep with waking at three in the morning, loss of interest in singing and reading, poor appetite with 5 kg weight loss, and withdrawal from friends, in a man of 58 under sustained political pressure; PHQ-9 22 with thoughts of being better off dead; depression suspected; medical causes being excluded and urgent psychiatric consultation arranged | resolved | confirmed | R53.83 | S — Synthetic presenting problem at intake, superseded by the diagnosis at the psychiatric consultation; anchored to his documented depression and loss of work (D). |
| Major depressive disorder, recurrent, severe, without psychotic features (second episode; structured diagnostic interview; MDQ negative and no past hypomanic or manic episode on interview) | active | confirmed | F33.2 | S — Synthetic modern diagnosis anchored to his documented depression after the 1955 breakdown (D); the bipolar interpretation (R) is addressed and not adopted. |
| Sustained political persecution: passport withheld, concerts and recordings cancelled, income lost, and surveillance by federal agencies; a major and realistic stressor, not a delusion | active | confirmed | Z60.5 | S — Synthetic coding of his documented persecution as a social determinant of his depression. |
| Acute bronchitis after a cold, without signs of pneumonia; treated without antibiotics and without dextromethorphan or decongestants because of venlafaxine; resolved | active | confirmed | J20.9 | S — Synthetic intercurrent illness; not a historical claim. |
Guideline basis: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention (2016)
Follow-up: Twenty-four-week review in four weeks as booked. Return sooner for fever or breathlessness. Call or text 988 at any time in a crisis. Next scheduled visit 2026-08-24: twenty-four-week review: partial response to venlafaxine; treatment-resistant depression; aripiprazole augmentation and an informed consent discussion about ECT. [S]